Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. The Bayer brand stands for trust, reliability, and quality throughout the world.

Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people.

Maven is the world's largest virtual clinic for women and families on a mission to make healthcare work for all of us. Maven's award-winning digital programs provide clinical, emotional, and financial support all in one platform, spanning fertility & family building, maternity & newborn care, parenting & pediatrics, and menopause & midlife. More than 2,000 employers and health plans trust Maven's end-to-end platform to improve clinical outcomes, reduce healthcare costs, and provide equity in benefits programs.

Recognized for innovation and industry leadership, Maven has been named to the Time 100 Most Influential Companies, CNBC Disruptor 50, Fast Company Most Innovative Companies, and FORTUNE Best Places to Work. Founded in 2014 by CEO Kate Ryder, Maven has raised more than $425 million in funding from top healthcare and technology investors including General Catalyst, Sequoia, Dragoneer Investment Group, Oak HC/FT, StepStone Group, Icon Ventures, and Lux Capital. To learn more, visit mavenclinic.com.

Pfizer is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines and vaccines that improve health and extend lives. For more than a century, Pfizer has combined leading science with a commitment to quality, safety, and patient access across areas such as oncology, vaccines, immunology, rare disease, and chronic conditions. In supporting employers, Pfizer works as a solutions‑oriented partner to help navigate rising healthcare costs, complex benefit decisions, and workforce health challenges. We provide science‑based education, insights on disease trends and high‑cost claims, and employer‑focused resources that support informed benefit design and employee engagement. Through collaboration with employer coalitions, consultants, and other stakeholders, Pfizer aims to improve access, affordability, and health outcomes while supporting productivity and population health goals.

Progyny is a leading family building and women's health benefits solution serving 600 clients, covering 7.2M lives in 45 industries. Created with diversity, equity and inclusion in mind, Progyny provides end to end reproductive health programs for the entire family building journey and serves self-insured and fully insured clients in the US, Canada and globally. Our family building and women's health services include: clinically integrated member support with robust digital tools (virtual care, app, etc.); the largest network of top providers with ongoing management for quality; equitable and comprehensive plan coverage; male fertility coverage; and targeted programming focused on reducing high risk journeys throughout the entire family building journey – including preconception, pregnancy, postpartum, and menopause. Since founding, Progyny has delivered superior clinical outcomes that exceed national averages and an unparalleled member experience. Progyny completed its initial public offering in 2019 and trades on Nasdaq under the ticker PGNY.